- Benowitz N.L. Clinical pharmacology of caffeine. Ann. Rev. Med. 1990, 41: 277–288.
Article PubMed CAS Google Scholar
- Kalow W., Tang B.K. The use of caffeine for enzyme assays: a critical appraisal. Clin. Pharmacol. Ther. 1993, 53: 503–514.
Article PubMed CAS Google Scholar
- Carrillo J.A., Christensen M., Ramos S.I., et al. Evaluation of caffeine as an in vivo probe for CYP1A2 using measurements in plasma saliva, and uriene. Therap. Drug Monit. 2000, 22: 409–417.
Article CAS Google Scholar
- Fuhr U., Klittich K., Horst Staib A. Inhibitory effect of grapefruit juice and its bitter principal, naringenin, on CYP1A2 dependent metabolism of caffeine in man. Br. J. Clin. Pharmacol. 1993, 35: 431–436.
Article PubMed Central PubMed CAS Google Scholar
- Curatolo P.W., Robertson D. The health consequences of caffeine. Ann. Intern. Med. 1983, 98: 641–653.
Article PubMed CAS Google Scholar
- Daly J.W., Fredholm B.B. Caffeine — an atypical drug of dependence. Drug Alcoh. Depend. 1998, 51: 199–206.
Article CAS Google Scholar
- Von Bahr C., Ursing C., Yasui N., Tybring G., Bertilsson L., Röjdmark S. Fluvoxamine but not citalopram increases serum melatonin in healthy subjects — an indication that cytochrome P450 CYP1A2 and CYP2C19 hydroxylate melatonin. Eur. J. Clin. Pharmacol. 2000, 56: 123–127.
Article Google Scholar
- Facciola G., Hidestrand M., von Bahr C., Tybring G. Cytochrome P450 isoforms involved in melatonin metabolism in human liver microsomes. Eur. J. Clin. Pharmacol. 2001, 56: 881–888.
Article PubMed CAS Google Scholar
- Härtter S., Ursing C., Morita S., et al. Orally given melatonin may serve as a probe drug for cytochrome P450 1A2 activity in vivo: a pilot study. Clin. Pharmacol. Ther. 2001, 70: 10–16.
Article PubMed Google Scholar
- Kall M.A., Clausen J. Dietary effect on mixed function P450 1A2 activity assayed by estimation of caffeine metabolism in man. Hum. Exp. Toxicol. 1995, 14: 801–807.
Article PubMed CAS Google Scholar
- Wurtman R.J., Lieberman H.R. Melatonin secretion as a mediator of circadian variations in sleep and sleepiness. J. Pineal Res. 1985, 2: 301–303.
Article PubMed CAS Google Scholar
- Dollins A.B., Zhadanova I.V., Wurtman R.J., Lynch H.J., Deng M.H. Effect of inducing nocturnal serum melatonin concentrations in daytime on sleep, mood, body temperature, and performance. Proc. Natl. Acad. Sci. U.S.A. 1994, 91: 1824–1828.
Article PubMed Central PubMed CAS Google Scholar
- Myers B.L., Badia P. Changes in circadian rhythms and sleep quality with aging: mechanisms and interventions. Neurosci. Biobehav. Rev. 1995, 19: 553–571.
Article PubMed CAS Google Scholar
- Snyder S.H., Sklar P. Behavioral and molecular actions of caffeine. Focus on adenosine. J. Psychiatr. Res. 1984, 18: 91–106.
Article PubMed CAS Google Scholar
- Leonard T.K., Watson R.R., Mohs M.E. The effects of caffeine on various body systems: A review. J. Am. Diet Assoc. 1987, 87: 1048–1053.
PubMed CAS Google Scholar
- Nehlig A., Daval J.L., Debry G. Caffeine and central nervous system: mechanism of action, biochemical, metabolic and psychostimulant effects. Brain Res. Rev. 1992, 17: 139–170.
Article PubMed CAS Google Scholar
- Piérard C., Beaumont M., Enslen M., et al. Resynchronization of hormonal rhythms after eastbound flight in humans: effects of slow-release caffeine and melatonin. Eur. J. Appl. Physiol. 2001, 85: 144–150.
Article PubMed Google Scholar
- Wright K.P. Jr., Badia P., Myers B.L., Plenzler S.C., Hakel M. Caffeine and light effects on nighttime melatonin and temperature levels in sleep-deprived humans. Brain Res. 1997, 747: 78–84.
Article PubMed CAS Google Scholar
- Salín-Pascual R.J., Ortega-Soto H., Huerto-Delgadillo L., Camacho-Arroyo I., Roldán G., Tamarkin L. The effect of total sleep deprivation on plasma melatonin and cortisol in healthy human volunteers. Sleep 1988, 11: 362–369.
PubMed Google Scholar
- Yeleswaram K., Vachharajani N., Santone K. Involvement of cytochrome P-450 isozymes in melatonin metabolism and clinical implications. J. Pineal Res. 1999, 26: 190–191.
Article PubMed CAS Google Scholar
- Härtter S., Wang X., Weigmann H., et al. Differential effects of fluvoxamine and other antidepressants on the biotransformation of melatonin. J. Clin. Psychopharmacol. 2001, 21: 167–174.
Article PubMed Google Scholar
- Härtter S., Grözinger M., Weigmann H., Röschke J., Hiemke C. Increased bioavailability of oral melatonin after fluvoxamine coadministration. Clin. Pharmacol. Ther. 2000, 67: 1–6.
Article PubMed Google Scholar
- Butler M.A., Iwasaki M., Guengerich F.P., Kadlubar F.F. Human cytochrome P450PA (1A2). the phenacetin Odeethylase is primarily responsible for the hepatic 3- demethylation of caffeine and N-oxidation of carcinogenic arylamines. Proc. Natl. Acad. Sci. U.S.A. 1989, 86: 7696–7700.
Article PubMed Central PubMed CAS Google Scholar
- Schmider J., Brockmoller J., Arold G., Bauer S., Roots I. Simultaneous assessment of CYP3A4 and CYP1A2 activity in vivo with alprazolam and caffeine. Pharmacogenetics 1999, 9: 725–734.
Article PubMed CAS Google Scholar
- Sabry I.I. Caffeine injection in the dark phase prolongs the nocturnal rise in serotonin N-acetyltransferase activity and melatonin content in the pineal gland of male rats. Endocr. Regul. 1997, 31: 207–210.
PubMed CAS Google Scholar
- Zatz M., Heath J.R. 3rd. Calcium and photoentrainment in chick pineal cells revisited: effects of caffeine, thapsigargin, EGTA, and light on the melatonin rhythm. J. Neurochem. 1995, 65: 1332–1341.
Article PubMed CAS Google Scholar